2019
DOI: 10.1016/j.apsusc.2019.04.106
|View full text |Cite
|
Sign up to set email alerts
|

Electrospun poly(styrene-co-maleic anhydride) nanofibrous membrane: A versatile platform for mixed mode membrane adsorbers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 21 publications
(2 citation statements)
references
References 40 publications
0
2
0
Order By: Relevance
“…So far, the versatility of electrospun membrane adsorbers has been studied primarily in terms of design, fabrication, and type of functionalization [ 19 ]. However, many of these adsorbers require multistep synthesis for functionalization [ 26 , 27 , 28 , 29 , 30 , 31 , 32 ], which limits their entrance into industry and the market. To overcome this, alternative fabrication routes, such as the use of pre-functionalized polymers should be explored [ 33 ].…”
Section: Introductionmentioning
confidence: 99%
“…So far, the versatility of electrospun membrane adsorbers has been studied primarily in terms of design, fabrication, and type of functionalization [ 19 ]. However, many of these adsorbers require multistep synthesis for functionalization [ 26 , 27 , 28 , 29 , 30 , 31 , 32 ], which limits their entrance into industry and the market. To overcome this, alternative fabrication routes, such as the use of pre-functionalized polymers should be explored [ 33 ].…”
Section: Introductionmentioning
confidence: 99%
“…Traditional column chromatography has high adsorption capacity and separation accuracy for protein [ 1 , 2 ]; so far, the downstream processing of biological agents has been highly dependent on the use of packed bed resin columns [ 3 , 4 ]. However, traditional column chromatography generally suffers from a high-pressure drop; the intraparticle diffusion leads to the accumulation of solute molecules, which made the processing time increases, low ligand utilization, and long treatment time, which limits its productivity [ 5 , 6 ]; meanwhile, column chromatography is expensive; more than 60% of the cost of the biopharmaceutical production process is concentrated in the downstream process of purification and recovery, in which the downstream purification of virus accounts for 70% of the total production cost [ 7 , 8 ].…”
Section: Introductionmentioning
confidence: 99%